AGP Picks
View all

US Culture & Style Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on US Culture & Style Today.

Press releases published on September 10, 2026

Snail Games to Present at the H.C. Wainwright 28th Annual Global Investment Conference on Monday, September 14, 2026, at 4:00 p.m. ET
Vistagen to Present at Psych Congress 2026
Intelligent Bio Solutions to Host Virtual Fireside Chat on September 24th at 4:30 p.m. ET
CCC to Present Exclusive First Look at the 2026 Copyrighted Content Usage Trends Report During a September LinkedIn Live Event
Amsterdamse kunstenaar transformeert kanaalafval tot mixed media-schilderijen in aanloop naar de Amsterdamse opruimdag.
Regency Centers to Present at the BofA Securities 2026 Global Real Estate Conference
Inuvo to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
NKGen Biotech to Present on Potential of Troculeucel in Neurodegenerative Diseases at Biologics Manufacturing Korea 2026
Starton Therapeutics to Present at MedInvest Biotech & Pharma Conference
Galectin Therapeutics to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Rhythm Pharmaceuticals Announces New Data Presentations at the European Society for Paediatric Endocrinology Meeting
Humacyte to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Aptera Motors Corp. to Participate in H.C. Wainwright 28th Annual Global Investment Conference
Taiwan Excellence Brings 61 Award-Winning Innovations and Interactive Experience to Taiwan Expo USA 2026
IN8bio to Present at H.C. Wainwright 28th Annual Global Investment Conference
Erasca Announces Multiple Presentations at the Upcoming 38th EORTC-NCI-AACR Symposium
electroCore to Participate at H.C. Wainwright Global Investment Conference
Legend Biotech to Present Updated Long-Term and Real-World Evidence from CARVYKTI Clinical Program at the International Myeloma Society Annual Meeting
Senseonics To Participate in Upcoming Institutional Investor Conferences
CervoMed Announces Initial Results from the Phase 2a Clinical Trial of Neflamapimod in Nonfluent Variant Primary Progressive Aphasia (nfvPPA) Have Been Accepted as a Late-Breaking Oral Session at ISFTD 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

US Culture & Style Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.